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Human induced pluripotent stem cells (hiPSCs) are a suitable tool to study basic molecular and cellular mechanisms of
neurodevelopment. The directed differentiation of hiPSCs via the generation of a self-renewable neuronal precursor cell line
allows the standardization of defined differentiation protocols. Here, we have investigated whether preconditioning with
retinoic acid during early neural induction impacts on morphological and functional characteristics of the neuronal culture
after terminal differentiation. For this purpose we have analyzed neuronal and glial cell markers, neuronal outgrowth, soma
size, depolarization-induced distal shifts of the axon initial segment as well as glutamate-evoked calcium influx. Retinoic acid
preconditioning led to a higher yield of neurons vs. glia cells and longer axons than unconditioned controls. In contrast,
glutamatergic activation and depolarization induced structural plasticity were unchanged. Our results show that the treatment
of neuroectodermal cells with retinoic acid during early development, i.e. during the neurulation phase, increases the yield of
neuronal phenotypes, but does not impact on the functionality of terminally differentiated neuronal cells.
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31Impact of preconditioning with retinoic acid during early development on hIPSC-derived neuronsIntroduction phase. Starting from one hiPSC line we generated two NPCThe reprogramming of adult somatic cells by expression of a
few defined transcription factors, such as Oct4, Sox2, Klf4
and c-Myc, was a milestone in stem cell research (Takahashi
and Yamanaka, 2006). Several applications for the resulting
human induced pluripotent stem cells (hiPSCs) have been
used since then for the generation of specific cell types for
transplantation or for drug testing in certain disease models
as well as studying basic cellular mechanisms in vitro. Since
biopsies from the human peripheral or central nervous
systems are rarely done, one focus lies on the generation of
human neuronal cells due to their potential to investigate
cellular and molecular aspects of mental diseases in vitro and
to develop new therapeutic approaches for these diseases.
Various protocols for the differentiation of neuronal cells from
hiPSCs have been established so far, using different method-
ologies to study cellular and functional aspects of the in vitro
generated neurons. These methods include quantification
of neurite length, soma size, synaptic connectivity, cell-type
specification, and neuronal excitability, e.g. (Brennand et al.,
2011; Falk et al., 2012; Kim et al., 2011; Prè et al., 2014; Shi et
al., 2012). With respect to functionality, Grubb and Burrone
presented a method to visualize activity-dependent neuronal
plasticity by immunofluorescence (Grubb and Burrone, 2010).
In rat hippocampal primary cultures chronic mild depolariza-
tion with KCl had been shown to induce a movement of the
axon initial segment (AIS) from the cell soma. This shift of the
AIS was only observed in excitatory neurons and was reversible
upon omission of KCl in the medium. The changes in the AIS
position correlated with increases in current thresholds for
action potential spiking indicating that the observed effects
rely on functional mechanisms.
For the reproducible neuronal differentiation of hiPSCs
a desirable beneficial step is the establishment of a self-
renewable neuronal precursor cell (NPC) line (Falk et al.,
2012; Marchetto et al., 2010). Such NPCs can be expanded
extensively and subsequently differentiated to a defined
neuronal population. The process of terminal neuronal differ-
entiation in vitro then lasts several weeks which reflects the
time-scale of the neuronal maturation in vivo (Kim et al., 2014;
McCormick andPrince, 1987). Here, gradients ofmorphogenetic
molecules including the vitamin A metabolite retinoic acid (RA)
are known to play pivotal roles for the developing central
nervous system (Maden, 2001, 2007). In recent years the effect
of retinoids on neuronal differentiation has also been studied in
vitro. This includes studies on the generation of neurons from
mouse embryonic stem cells (Bain et al., 1996; Bibel et al.,
2004; Rochette-Egly, 2014) and from hiPSCs (Sartore et al.,
2011; Shi et al., 2012; Verpelli et al., 2013). Furthermore, RA
has also been used for the differentiation of the teratocarcino-
ma line NCCIT (Gasimli et al., 2013), the neuronal differenti-
ation of the human SHSY5Y neuroblastoma cells (Påhlman et al.,
1984) and of mononuclear cells from peripheral blood
(Horschitz et al., 2010). Moreover, RA has been applied for the
neural differentiation of P19 mouse pluripotent carcinoma cells
(Chen and Reese, 2011). In the latter case differentiation could
also be inducedwith the RA precursor retinol, althoughwith 160
fold less efficiency.
In the present study we have analyzed the influence of RA
treatment on early developing NPCs, i.e. during the neurulationlines only one of which was treated with RA already during
the neurulation phase, whereas in both lines addition of RA
was omitted after generation of NPCs and during terminal
differentiation. The resulting NPCs were then analyzed for the
expression of typical marker proteins. In addition, a differen-
tial transcriptome expression analysis was performed in the
two generated NPC lines. Next, we studied the impact of early
RA treatment on morphological and functional features of
the differentiated neurons. In summary, our findings show
that treatment with RA during NPC development signifi-
cantly promotes neuronal versus glial differentiation and
hereby influences neurite length and soma size. With respect
to functional aspects preconditioning with RA during early
development did not affect activity-dependent movement of
the AIS from the cell soma nor glutamate-evoked calcium
transients.
Materials and methods
Human induced pluripotent stem cell culture and
generation of neuronal precursor cell lines
The generation of the hiPSC line was performed according to
the method of Maherali et al. (Maherali et al., 2008). Briefly,
hiPSCs were derived from dermal fibroblasts of a healthy donor
with an inducible polycistronic lentiviral reprogramming vector
coding for the four reprogramming genes Oct4, Sox2, Klf4, and
c-Myc (Somers et al., 2010) (Ethics Committee II of Heidelberg
University approval no. 2009-350N-MA for hiPSC generation).
Human iPSCs were cultured on hESC-qualified Matrigel (BD
Biosciences) in defined mTeSR medium (Stemcell Technolo-
gies). Cells were split 1:6 every 5–7 days using 1 mg/mL dispase
(Stemcell Technologies).
To initiate differentiation cells were resuspended in KO-
DMEM/F12 medium supplemented with 1% N2 (both Invitrogen)
after dispase treatment and triturated carefully to single cells,
first, using a 5 ml-pipette, second, a 200 μL-pipette, and
finally, a glass pasteur pipette. Embryoid bodies (EBs) were
formed according to the method described by Ungrin et al.
(Ungrin et al., 2008). Here, 10,000 cells per well were seeded
in a V-bottom shaped 96well plate coated with Pluronic F-127
(Sigma) to prevent cell attachment. The plate was centrifuged
at 200g for 5 min. The next day, aggregates were scraped with
a wide bore 1000 μL-tip and transferred to a bacterial-grade
Petri dish. During floating culture the KO-DMEM/F12 medium
was supplemented with 1% N2, 50 ng/mL noggin (Stemgent),
500 nM dorsomorphin (Tocris), 1 μM SB431542 (Sigma). Here,
one cell line was preconditioned with 1 μM retinoic acid (RA;
Sigma); this line is termed NPC+RA throughout themanuscript. A
second, independent line did not receive RA treatment
(NPC−RA). After four days of floating culture, EBs were plated on
Matrigel-coated 6well plates in the same medium. When EBs
attached to the plate (after 1–3 days) medium was changed
to DMEM/F12 GlutaMAX supplemented with 1% N2, 2% B27,
2 mM L-glutamine, 100 μM MEM nonessential amino acids (all
Invitrogen) and 20 ng/mL bFGF (R&D Systems). Neural rosette
structures became visible after 10–14 days. Rosettes were
picked with a needle and replated on Matrigel-coated 6well
plates in the same medium. The highly proliferating cells were
passaged approximately every two days 1:4 in the beginning.
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achieved. NPCs were cultured on poly-L-ornithine (Sigma)
coated plates from then on with a split ratio of 1:2 once a
week. The cells can be cryo-preserved in mFreSR medium
(Stemcell Technologies) andwere kept in culture up to passage
20 until now.
Directed differentiation of NPCs
For terminal neuronal differentiation both NPC lines, NPC+RA
and NPC−RA, respectively, were seeded on Matrigel-coated
6well plates with 1.5 * 105 cells/well in DMEM/F12 GlutaMAX
with 1% N2, 2% B27, 2 mM L-glutamine, 100 μM MEM nonessen-
tial amino acids and 20 ng/mL bFGF. On the next day
differentiation was induced by bFGF withdrawal in the same
medium. Since no other growth factors were applied, cells
developed a mainly glutamatergic phenotype by a default
mechanism (Stern, 2001). Mediumwas changed every other day
and the neuronal culture survived up to 100 days.
Immunofluorescence, neuronal growthmeasurements
and quantifications
For immunofluorescence analyses cells were grown on
Matrigel-coated glass cover slips. At certain time points
cells were fixed in 4% paraformaldehyde for 15 min at room
temperature, washed in PBS and permeabilized with 0.1%
Triton X-100 and 0.1% Na-citrate in PBS for 3 min at 4 °C.
Afterwards, cells were blocked for 1 h in blocking solution
(0.1% gelatine, 10% horse serum in PBS) at room tempera-
ture. Primary antibodies were diluted in blocking solution
and incubated with the cells for 45 min at room tempera-
ture (antibodies and dilutions are listed below) (Table 1).
Secondary antibodies conjugated to Alexa fluorophores
(Invitrogen) were diluted 1:1000 and incubated for 45 min
at room temperature before mounting the cells with
ProlongGold (Invitrogen).
For quantification experiments cells were stained with
the nuclear dye TOTO-3 diluted 1:200 together with the
secondary antibodies. Images were acquired on a Leica TCS
SP5 confocal laser scanning microscope using either an ×20
or an ×63 oil planachromat lens (Leica Microsystems). All
images were processed using ImageJ (NIH). Neurite tracingsTable 1 List of applied antibodies, the respective supplier,
and experimental dilution.
Antibody target (source) Supplier Dilution
Oct3/4 (rat) R&D Systems 1:100
Sox2 (gt) Santa Cruz 1:200
Pax6 (rb) Covance 1:200
Nestin (rb) Abcam 1:500
Tau (gp) Synaptic Systems 1:200
Map2a (ms) Abcam 1:200
β-tubulin III (rb) Synaptic Systems 1:200
vGlut1 (gp) Synaptic Systems 1:500
GAD1 (rb) Synaptic Systems 1:200
GFAP (ms) Synaptic Systems 1:500
AnkG (ms) Neuromab 1:100were performed with the ImageJ plugin NeuronJ. Statistical
analysis was performed using GraphPad software.
Flow cytometry
Cells were trypsinized and resuspended in culture medium.
For each trial 5*105 cells were centrifuged and resuspended
in FACS staining buffer (Becton Dickinson) and incubated for
20 min with APC-labelled anti-CD133 (1:10; Miltenyi Bio-
tech) at room temperature. Cells were washed twice and
measured with a Becton Dickinson FACS Calibur cytometer.
10,000 events were acquired per measurement and analyzed
using the CellQuest Pro software. Isotype controls were
taken from each cell line using APC-labelled mouse IgG1
antibody (AbD Serotec).
Transcriptional analysis
Total RNA was isolated with Trizol (Invitrogen) from NPC−RA and
NPC+RA lines. A differential gene expression analysis was
performed by GATC Biotech (InView Transcriptome Explore;
GATC Biotech). Gene expressionwas analyzed using the Bowtie,
TopHat, Cufflinks, Cuffmerge, Cuffdiff software suite.
Calcium imaging
For calcium imaging experiments NPCs were differentiated on
Matrigel-coated 35 mm μ-dishes (Ibidi) with 2 * 105 cells/dish.
First experiments were performed after 50 days of terminal
differentiation. Cells were transferred into extracellular solu-
tion (Tyrode's solution) containing NaCl 137.6 mM, KCl 5.4 mM,
MgCl2 0.5 mM, CaCl2 1.8 mM, glucose 5 mM and HEPES 10 mM
(Roth), and were loaded with 3 μM FURA-2 AM (Calbiochem)
and same amount (in μL) of Pluronic F-127 (Calbiochem) for
45–60 min at room temperature protected from light. Cells
were washed twice with extracellular solution and mounted on
the stage of an inverted microscope (Olympus IX81 equipped
with cellR Imagingsystem). During the experiments cells were
superfused with Tyrode's solution (1–3 mL/min) at room
temperature. After alternating excitation with light of 340 nm
and 380 nm wavelength, the ratio of the fluorescence emission
intensities at 510 nm (340 nm/380 nm [510 nm]) was calculat-
ed and digitized at 1 Hz by an ORCA-R2 camera (Hamamatsu
Photonics). This fluorescence ratio is a relative measurement of
intracellular calcium concentration (Grynkiewicz et al., 1985).
Regions of interest were drawn around cells which could easily
be distinguished from adjacent cells. Relative changes in
intracellular calcium were calculated by dividing the peak
values by the initial baseline. An increase of N23% in response to
100 μM glutamate was considered significant (Greffrath et al.,
2001), and only these cells were used for subsequent analyses.
Normalization of calcium transients was performed by setting
themaximum responses seen in an independent culture to 100%
and adjusting all others accordingly.
Data analysis
Statistical analysis for neurite length measurements was
performed with GraphPad Prism 3.0 in terms of One-way
ANOVA followed by post-hoc Tukey's multiple comparison
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t-test. The chosen level of significance was p b 0.01.
Results
Retinoic acid impacts on axonal growth of
hiPSC-derived neuronal cultures
For the reproducible induction of hiPSC-derived neuronal
cell cultures we aimed to generate self-renewable NPC lines
since this method has the advantage to make the hiPSC
culture dispensable once the NPC stadium is achieved. HiPSC
and NPC lines were generated as described in the Materials
and methods section (2.1 and 2.2). In the phase of neural
induction NPC generation was performed in the absence and
presence of RA during floating culture which resulted in the
generation of two NPC lines, termed NPC−RA and NPC+RA.
Both NPC lines were used between passage #10–20 for all
here described experimental work. Cellular states were
monitored during NPC generation and the two NPC lines
were analyzed for the expression of neuronal precursor
proteins Pax6, Nestin and Sox2 by immunofluorescence as
well as for CD133/PROMININ (Uchida et al., 2000) by FACS
(Fig. 1). No differences were observed between NPC−RA and
NPC+RA in these analyses.
NPCs were cultured in the presence of bFGF and a
simple withdrawal of the growth factor induced a terminalFigure 1 RA does not alter cellular states during differentiation of
Matrigel. (B) Arising neural rosettes 7 days after plating of EBs on M
replated rosettes (picture of NPC+RA). (D) Neuronal networks in
withdrawal. (E, F) Staining of Sox2 (red) and the neural precursor pr
the neural precursor protein Pax6 in NPC+RA and in NPC−RA. Left
magnification. All stainings were performed at least three times (n N
surface protein CD133/PROMININ is shown for both established NPC
corresponds to the secondary antibody isotype negative control. Scadifferentiation into mainly glutamatergic neurons. For a
morphological comparison between NPC−RA and NPC+RA we
monitored neuronal growth by measuring neurite lengths and
soma sizes (Fig. 2). At certain time points differentiating cells
were fixed and the length of the axons were determined after
performing an immunofluorescent staining against the axonal
protein tau. Accordingly, the length of the dendrites was
measured after staining for the somatodendritic marker
protein MAP2a. Here we found a remarkable difference
between NPC−RA and NPC+RA: As shown in Fig. 2B, the length
of the axons of NPC+RA-derived neurons was significantly longer
compared to NPC−RA-derived neurons. This was observed
already at day 5 of terminal differentiation whereas no
significant differences were seen with respect to the
dendrite length of the two cell lines over a differentiation
period of 4 weeks. Regarding the soma size both cell lines
showed a dramatic shrinkage in the beginning of differen-
tiation until day 8, whereas no significant differences
between NPC−RA and NPC+RA were observable.
Early retinoic acid treatment impacts on the cellular
phenotype of differentiating neurons
Next, we compared the composition of the cell culture with
respect to cellular phenotypes at certain time points during
the first 51 days of differentiation. Immunofluorescence
analyses were performed for the neuronal marker proteinshiPSCs to NPCs. (A) A representative colony of hiPSCs growing on
atrigel. (C) A monolayer of NPCs after two further splittings of
differentiating NPCs (NPC+RA) at day 53 after growth factor
otein Nestin (green) in NPC+RA and in NPC−RA. (G, H) Staining of
lower squares in (C) to (H) show a section of cells in higher
3). (J) A representative FACS analysis of the neural-specific cell
lines (NPC−RA, red, and NPC+RA, blue); (n = 2). The black line
le bar in inset (C) 10 μm, all other scale bars 50 μm.
Figure 2 Early RA treatment during NPC generation promotes axonal outgrowth. Differentiating cells were stained at the indicated
time points for the axonal marker protein tau and the somatodendritic marker protein MAP2a. The neurite lengths and soma sizes were
determined with the plugin NeuronJ of the ImageJ software. A representative picture with appropriate tracings for MAP2a stained
neurons of the NPC+RA line on day 14 of differentiation is shown in (A). Yellow arrows point to beginning and ending of respective neurites.
Scale bar 200 μm. The graphs show in (B) the lengths of dendrites ( , ) and axons ( , ) of NPC−RA, red, and NPC+RA, blue, respectively.
For NPC+RA axons were significantly longer than dendrites whereas no significant difference was observed for NPC−RA (one-way Anova;
p b 0.01). In (C) the shrinkage of the somas of the corresponding cell lines (NPC−RA, red, NPC+RA, blue) until day 28 of differentiation is
shown. No significant differences between the two cell lines were observed (unpaired t-test; p N 0.05). At least 50 cells were measured
per graph point. The graphs show results obtained from one representative differentiation; the whole experiment was performed three
times with NPC+RA and twice with NPC−RA with similar results.
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GFAP in order to determine the proportion of neuronal and glial
cells. In addition, stainings for the cell type specific proteins
vGlut1 and the GABA synthesizing protein GAD1 were per-
formed. In all immunofluorescences the nuclear cell dye
TOTO-3 was applied to enable quantifications. Typical immu-
nofluorescence stainings are shown in Fig. 3C,where, however,
the TOTO-3 staining is omitted for a better visualization of the
cell type specific markers. In the quantification experiments
the amount of MAP2a-positive cells and tau-positive cells were
comparable to the amount of β-tubulin III-positive cells.
Therefore in Fig. 3A only the results for β-tubulin III
quantification are given as neuronal cell marker. In Fig. 3A
it is shown that for both NPC lines the proportion of
neuronal cells decreased during terminal differentiation
while the proportion of glial cells rose. Importantly, at day 51
of differentiation neural cultures derived from NPC−RA
consisted of 23 ± 7% neurons and 75 ± 3% glial cells, whereas
cultures derived from NPC+RA consisted of 42 ± 5% neurons
and 53 ± 11% glial cells. In both NPC lines the proportion of
glutamatergic and GABAergic neurons rose within the neuronal
subpopulation during terminal differentiation (Fig. 3B). At day
51 up to 80% glutamatergic neurons were determined for
the NPC−RA line and up to 90% glutamatergic neurons for the
NPC+RA line. GABAergic neurons were detectable in both lines,
but with a distinct proportion only at day 51 of differentiation
in both NPC lines (Fig. 3B).
Differential gene expression analysis of NPC−RA and
NPC+RA lines
A comparative transcriptome analysis of NPC−RA and NPC+RA
lines revealed RA-induced up-regulation of many neuronal
genes as well as of several transcription factors. An exemplary
overview of a selection of significantly up-regulated geneswhich are involved in neurodevelopment or neuronal
differentiation is presented in Table 2. Detailed informa-
tion of the total gene expression analysis is found under
Supplementary data.Early retinoic acid treatment does not influence AIS
movement in glutamatergic neurons
The axon initial segment (AIS) is a specialized region in
neurons where the action potential is initiated. It is located
near the axon hillock and it comprises several AIS specific
proteins, including AnkyrinG (AnkG), which is used here for an
immunofluorescent localization of the AIS region. It was shown
by Grubb and Burrone (2010) that chronic mild depolarization
of glutamatergic neurons from rat hippocampal cultures
induced a distal shift of the AIS. This movement was reversible
and was not observed in GABAergic neurons (Grubb and
Burrone, 2010). Here, neuronal cultures were depolarized by
cultivation in neuronal differentiation medium containing
15 mM K+ for two days at 37 °C with 5% CO2. Control cultures
were kept under the same conditions but without KCl addition.
Afterwards, the cells were either fixed with 4% PFA or further
cultivated for another two days in normal neuronal differen-
tiation medium for recovery experiments and fixed thereaf-
ter. Immunofluorescent analyses were performed at day 50
of terminal differentiation for AnkG and the glutamatergic
marker vGlut1 or the GABAergic marker GAD1, respectively.
As shown in Fig. 4, mild chronic KCl treatment induced a
significant distal AIS shift from the cell somata only in
glutamatergic, but not in GABAergic neurons. This shift did not
significantly differ between NPC−RA and NPC+RA-derived
neurons (17.91 ± 1.07 μm and 13.03 ± 1.13 μm, respectively)
and was reversible in both cell lines. At least 40 cells were
analyzed per graph point.
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neuronal excitability by glutamate
Microfluorimetric measurements of free intracellular calcium
were performed using the calcium dye FURA-2-AM in neuronal
cultures after day 50 of terminal differentiation (n = 3 for
NPC−RA and NPC+RA, each). Application of glutamate (100 μM)
induced a significant rise (N23%) in intracellular calcium
in about half of all cells of NPC+RA under investigation
(45.2 ± 24.4%; Fig. 5, left column); for NPC−RA the respond-
er rate was nominally lower (15.3 ± 6.1%). However, due to
large variation seen between cultures (responder rates from 4.2
to 94%) this difference did not reach statistical significance.
Glutamate evoked calcium transients displayed concentration
dependence, the EC50 values were 16.6 μM and 19.1 μM (Hill
slopes 0.63 ± 0.18 and 0.57 ± 0.13), respectively, and did not
differ between treatments (log10 EC50 = −4.78 ± 0.26 and
−4.72 ± 0.17; p N 0.30, student's t-test; Fig. 5C). Glutamate-
induced Ca2+ influxes were completely blocked by 10 μM CNQX
but not affected by 20 μM APV (data not shown).
Discussion
All-trans retinoic acid (RA), a metabolic compound derived
from vitamin A, is well-known to play a pivotal role during the
developing nervous system by activating nuclear receptors
which are ligand-inducible transcription factors. In vivo RA
contributes to patterning of the neural plate and neural tube
in a concentration-dependent manner (Hansen et al., 2011;
Maden, 2007) and it is required for cortical neurodevelopment
(Siegenthaler et al., 2009). During in vivo brain development RA
induces the differentiation of glia and other cells by activation
of the transcription of many genes encoding transcription
factors, enzymes, structural proteins as well as RA-inducible
repressor genes (Maden, 2001).
Also in vitro RA has been shown to have a time- and
concentration-dependent effect on neurodevelopment (Tonge
and Andrews, 2010) and to induce different neuronal pheno-
types from embryonic stem cells. In recent years most RA-
related studies have been performed with mouse ES cells
(Bain et al., 1996; Bibel et al., 2004; Rochette-Egly, 2014).
Compared to human ES or iPS cells these cells often show
differences in their neuronal in vitro cultures, especially
regarding culture conditions or the time-scale of their
neurodevelopment. In this line RA alone can induce the
differentiation of glutamatergic neurons, together with sonic
hedgehog (SHH) the differentiation of cholinergic and dopami-
nergic neurons, and together with ciliary neurotrophic factor
(CNTF) the differentiation of dopaminergic neurons frommouse
embryonic stem cells (for review see (Maden, 2007)). With
respect to neuronal differentiation of hiPSCs it was demon-
strated recently that the generation of glutamatergic neurons
depends on the presence of RA (Zeng et al., 2010), and that the
presence of RA is absolutely crucial for the development of
cortical neurons with marker expression of all cortical layers
(Shi et al., 2012). When comparing the literature for the impact
of RA on neuronal differentiation from hiPSCs it is noticeable
that there is a high diversity in i) the applied RA concentrations,
ii) in the starting time point of application and iii) in the
duration of the treatment during neuronal differentiation
(Brennand et al., 2011; Chambers et al., 2009b; Falk et al.,2012; Marchetto et al., 2010; Shi et al., 2012; Tonge and
Andrews, 2010). With this respect, several protocols for
neuronal differentiation of human stem cells including iPSCs,
have been reported (for overview see (Kim et al., 2014)). Based
on a protocol of Zhang and colleagues (Zhang et al., 2001)
neural commitment of ES cells or hiPSCs often starts with
the formation and culturing of EBs for a short period of time.
Then the EBs are grown in adherent culture in defined
media containing N2 and B27 supplements and bFGF until the
formation of “neural rosettes.” These are then manually
isolated and replated in Matrigel-coated plates until a homoge-
neous culture of NPCs is achieved which can be finally
differentiated to neurons, astrocytes and oligodendrocytes
both in vitro and in vivo (Zhang et al., 2001). Here, bioactive
RA is known to exert caudalizing effects during CNS develop-
ment in vivo and during neural differentiation of stem cells in
vitro (Allodi and Hedlund, 2014; Liu and Zhang, 2011). For
example, continuous addition of 1 μMRA to NPCs from day 3 of
differentiation favoured the final differentiation to motor
neurons (Lippmann et al., 2014). In another approach Amoroso
and colleagues have added RA from day 5 after EB formation
consequently for 31 days which resulted in efficient motor
neuron differentiation (Amoroso et al., 2013).
At this point it is worthwhile mentioning, that the B27
supplement can be purchased containing 0.3 μM retinyl acetate
which is a biologically inactive storage form of vitamin A.
However, only dietary retinol bound to the retinol binding
protein 4 (RBP4) is taken up into cells where it can then be
stored either as retinyl esters or oxidized in two steps to the
bioactive metabolite RA (Chen and Reese, 2011; Napoli, 2012;
Orsolits et al., 2013). Interestingly, only some cell types seem to
have the ability to take up retinol/RBP4 and to metabolize
retinol to RA inside the cell. Newer data suggest that RA
synthesized in one cell type can act on adjacent cells. This
paracrine signalling is a common theme in development and
the differentiation of cells in vitro (Gudas and Wagner,
2011).
In the present study we aimed to analyze the effect of
early retinoid signalling already during the neural induction
phase on the development of the neuronal culture. There-
fore, two NPC lines were generated (NPC−RA and NPC+RA) one of
which was treated with RA during the initial neural induction
phase of EB formation (NPC+RA). Thereafter both lines were
treated equally, i.e. in the absence of biologically active RA
in the culture medium. In the early phase of differentiation no
difference in number or size of formed EBs was observed and
also the onset of rosette formation was comparable. Both NPC
lines were morphologically similar and did not differ within the
expression of neural precursor marker proteins such as
Pax6, nestin or Sox2, indicating that RA treatment during
the neurulation phase did not influence NPC properties so far.
A comparative transcriptome analysis of the two cell lines
revealed a RA-induced expression of the transcription factor
FoxG1 which is required for early telencephalon patterning
(Hebert and Fishell, 2008) and, on the other hand, also of
HoxA1 which is involved in hindbrain patterning (Chambers et
al., 2009a). These findings suggest that early RA treatment
induces a more general neuronal commitment of the NPCs
whereas RA activity is needed also during later phases of
development for hindbrain/spinal cord differentiation. To
elucidate these interactions in more detail, a gene expression
analysis of terminally differentiated neurons in the absence
Figure 3 Early RA treatment influences cellular composition of differentiating neurons. (A) Specific marker proteins were stained by
immunofluorescence at defined time points during differentiation together with the cell nuclear stain TOTO-3 and quantified using the
ImageJ software. At least 50 cells were analyzed per staining and time point from at least three individual differentiations per cell line. In
both NPC lines, NPC−RA and NPC+RA, the proportion of neuronal cells (β-tubulin-positive cells, green lines) decreased until day 51 of
differentiationwhile the proportion of glial cells (GFAP-positive cells, yellow lines) rose accordingly. This effect is observed in the NPC−RA line
to a higher extent: at day 51 the culture consisted of 23 ± 7% neuronal cells (green line, left graph) and 75 ± 3% glial cells (yellow line, left
graph) compared to 42 ± 5% neuronal cells (green line, right graph) and 53 ± 11% glial cells (yellow line, right graph) in the NPC+RA line. In
both cell lines the percentage of GABAergic cells (GAD1-positive, blue lines) is low during differentiation while the amount of glutamatergic
cells steadily rises in RA-treated cells (red line). (B)Within the neuronal population (quantifications in relation toβ-tubulin-positive cells) the
percentage of glutamatergic cells (vGlut1-positive cells, red lines) increased to N80% for NPC−RA (left graph) and to N90% for NPC+RA (right
graph) during differentiation. The amount of GABAergic cells (GAD1-positive, blue lines) was quite low in both cell lines and rose within the
neuronal population up to 20% for NPC−RA and up to 15% for NPC+RA at day 51. In (C) representative stainings are shown for β-tubulin and
vGlut1 (left), for MAP2a and GAD1 (middle), and for GFAP and β-tubulin (right). All displayed stainings were performed with NPC+RA-derived
neurons at different time points of terminal differentiation: d26 (β-tubulin + vGlut1), d51 (MAP2a + GAD1), d33 (GFAP + β-tubulin). Scale
bars 50 μm.
36 S. Horschitz et al.versus presence of RA would be needed. In this regard, Paschaki
and colleagues have performed a comparative transcriptome
analysis of anterior and posterior tissues of murine embryos
lacking the endogenous RA synthesizing enzyme retinaldehydedehydrogenase 2 (Paschaki et al., 2013). These studies
conducted at early stages of embryonic development
revealed a down-regulation of the anterior FoxG1 as well
as of the posterior HoxA1 in the RA-deficient mice.
Table 2 Selection of significantly up-regulated genes in NPC+RA which are functional in neurodevelopment and differentiation.
Symbol Name Function Expression rate
NPC−RA NPC+RA
CNTN2 Contactin 2 (axonal) Contributes to the organization of axonal domains 0.507 813.788
GRIK3 Glutamate receptor, ionotropic, kainate 3 Ligand-gated ion channel which plays an important role
in excitatory synaptic transmission
330.134 700.422
SYT6 Synaptotagmin VI Involved in Ca(2+)-dependent exocytosis of secretory
vesicles
0.199 181.408
GAD2 Glutamate decarboxylase 2 Catalyzes the production of GABA 0 171.966
GFRA1 GDNF family receptor α1 Plays key role in the control of neuron survival and
differentiation
0.656 110.978
SLC17A8 Vesicular glutamate transporter Transports glutamate into synaptic vesicles 0 278.886
TBX3 T-box transcription factor 3 Transcriptional repressor and is thought to play a role in
the anterior/posterior axis of the tetrapod forelimb
0 317.788
FOXG1 Forkhead box protein G1 Regulation of transcription; may play a role in brain
development
0 270.053
NRXN3 Neurexin-3-alpha Cell adhesion molecule involved in synaptic
plasticity
0 201.342
HOXB3 Homeobox protein B3 Regulation of transcription 0 359.795
CACNA1A Cav2.1 P/Q voltage-dependent calcium channel Mediates the entry of calcium ions into excitable cells 0 620.947
DLX1 Homeobox protein DLX1 Transcriptional regulator of signals frommultiple TGF-β
superfamilymembers;may play a role in differentiation
and survival of inhibitory neurons in the forebrain
0 246.376
SLC32A1 Vesicular inhibitory amino acid transporter GABA and glycine uptake into synaptic vesicles 0 280.714
TM4SF1 Transmembrane 4 L6 family member 1 Mediates signal transduction events that play a role
in the regulation of cell development, activation,
growth and motility
0 501.596
SST Somatostatin Regulates the endocrine system and affects
neurotransmission and cell proliferation
0 730.345
TFAP2B Transcription factor AP-2β Stimulates cell proliferation and suppresses
terminal differentiation
0 172.863
HOXA1 Homeobox protein A1 Regulation of transcription 0 534.145
HOXA3 Homeobox protein A3 Regulation of transcription 0 368.739
HOXA7 Homeobox protein A7 Regulation of transcription 0 109.836
NPTX2 Neuronal pentraxin II Involved in excitatory synapse formation 382.262 505.677
STMN2 Stathmin-2 Functions in microtubule dynamics and signal
transduction; plays a regulatory role in neuronal growth
179.557 782.711
Expression rates are given in fragment per kilobase per million mapped reads (FPKM). Threshold for significance is the false discovery rate
(FDR) adjusted p-value of test statistic for log2 (fold change) analyzed with Cuffdiff software (b5%).
37Impact of preconditioning with retinoic acid during early development on hIPSC-derived neuronsIn the transcriptome analysis of our NPC lines, the
expression of several neuronal transcripts including various
proteins involved in synaptic transmission was significantly
up-regulated in the NPC+RA sample. Interestingly, these
included GABAergic genes, such as the vesicular GABA trans-
porter and glutamic acid decarboxylase 2, as well as transcripts
involved in glutamatergic neurotransmission like the vesicular
glutamate transporter vGLUT3. Glia-specific transcripts, how-
ever, were not up-regulated in the NPC+RA samples again
suggesting that early RA treatment favours neuronal versus glial
differentiation.
In order to investigate properties of terminally differen-
tiated neurons we analyzed morphological aspects and the
cellular composition of the NPC-derived cultures. Interest-
ingly, the quantification of neuronal outgrowth revealed that
early RA treatment promotes axonal growth which led to the
development of neurons with axons twice as long as the
dendrites. This corresponds to Dotti's model of a functional
neuron (Dotti et al., 1988) and was only found indifferentiated neurons of the NPC+RA line. In addition, after
50 days of terminal differentiation neural cultures derived
from NPC+RA contained significantly more neurons as com-
pared to NPC−RA which contained more glial cells. In this
context it has been described that a passage number of N20 of
a NPC line raises the glial proportion within the neuronal
culture (Tang et al., 2013), however, all here described
experiments with both of the NPC lines (NPC−RA and NPC+RA)
were performed during passages #10–20 of the NPCs. There-
fore, we conclude from our observations and the transcriptomic
analysis that the RA treatment during early neurulation has a
beneficial effect on the neurodevelopment since more neurons
survive during terminal differentiation stages in the NPC+RA line
compared to the NPC−RA line. Since terminal differentiation is
induced by bFGFwithdrawal it should bementioned that RA and
FGF have an interesting regulatory relationship in morphogen-
esis (Casci, 2008; White et al., 2007). In this study it was
suggested that removal of FGF may effectively up-regulate RA
signalling. This, however, should not play a role in our study
Figure 4 Early RA treatment has no influence on AIS movement. For visualization of the AIS the protein AnkyrinG was stained by
immunofluorescence. As marker proteins vGlut1 was used for glutamatergic cells (A, C, E) and GAD1 for GABAergic cells (B, D). Cells were
either untreated (A + B) or chronically depolarized with 15 mM K+ (C + D), and fixed with 4% PFA afterwards. For recovery experiments cells
were kept in 15 mM K+ for 2 days and for further 2 days in neuronal differentiationmedium and fixed afterwards (E). Representative Figures
A, B, C, D, and E were obtained with the NPC−RA line. In Figures A–E white arrows point to the beginning and ending of the AIS region
(AnkyrinG staining) and a yellow arrow indicates the corresponding cell soma, respectively. Scale bars 10 μm. (F) Quantification of distal AIS
shifts. The AIS moves significantly in glutamatergic neurons derived from NPC−RA and NPC+RA ( , ; p b 0.0001, student's t-test). This shift is
reversible upon removal of KCl for 2 days. No KCl-induced shift was observed in GABAergic neurons derived from NPC−RA and NPC+RA,
respectively ( , ). At least 40 cells were analyzed per data point from at least three individual experiments per cell line.
38 S. Horschitz et al.since we apply RA during EB formation in the absence of bFGF,
and apply bFGF only in later phases.
One hypothesis for the observed effects of early RA
treatment could be the fact that RA acts on retinoic acid
responsive elements (RAREs) which are among others located
at the promoter of the pluripotency transcription factor Oct4
(Pikarsky et al., 1994). Thereby Oct4 gets down-regulated andin combination with the triple SMAD inhibition with the neural
inductors noggin, dorsomorphin and SB431542, the cells are
directed to a neural fate. Thus, early RA treatment may
positively impact on this development. In a comparable
approach RA treatment had been shown to alter the
oligosaccharide cell surface antigen expression of terato-
carcinoma NCCIT cells during their neuronal differentiation
Figure 5 Calcium imaging reveals similar glutamate sensitivity of NPC−RA and NPC+RA derived neurons. FURA-2 ratiometric calcium
transient imaging was performed in hiPSC-derived neuronal cultures at least at day 50 of terminal differentiation. (A) False colour
pictures of representative experiments displaying cells before glutamate application (Pre), challenged with different concentrations
of glutamate, and after depolarization using 140 mM extracellular potassium solution. (B) Calcium changes over time of the two
representative cells of NPC+RA (left)/NPC−RA (right) marked with arrows in (A), respectively. Glutamate concentrations are indicated
at the top. (C) Mean dose response curves for NPC lines (mean ± SEM). EC50 values are indicated by dashed lines. Shown graphs are
representative for one experiment (n = 3 per cell line). Left columns display NPC+RA, on the right NPC−RA.
39Impact of preconditioning with retinoic acid during early development on hIPSC-derived neuronsand also to increase the expression of the decorin core
protein which is known to promote axonal growth (Gasimli
et al., 2013; Minor et al., 2008). Whether comparablemechanisms may underlie the development of longer axons
in the RA treated cell line NPC+RA remains to be
investigated.
40 S. Horschitz et al.Furthermore, we assessed the excitability of the differentiated
neurons by quantifying glutamate-induced calcium influx
and by activity-dependent AIS movements. The latter is an
immunofluorescence-based method to visualize activity-
dependent neuronal plasticity in developing neurons:
With this respect Grubb and Burrone had shown that
chronic mild depolarization of glutamatergic neurons from
rat hippocampal cultures induced a distal shift of the
AIS from the cell soma (Grubb and Burrone, 2010). This
movement was reversible and not seen in GABAergic
neurons. Comparably to Grubb and Burrone also we
observed in our study a KCl-induced, reversible distal
shift of the AIS only in glutamatergic neurons with the
magnitude of the analyzed shift corresponding to the
measurements performed in rat hippocampal neurons
(Grubb and Burrone, 2010). Hereby, the distance of the
AIS movement did not significantly differ in NPC−RA and
NPC+RA derived neurons, respectively.
Quantification of glutamate-evoked calcium transients did
not reveal any differences between NPC−RA and NPC+RA derived
neurons. In both lines, glutamate dose-dependently evoked
Ca2+ influx with an EC50 value of 15–20 μM. Because Ca2+
measurements were performed in the presence of Mg2+ and in
the absence of the NMDA-coactivator glycine and glutamate-
induced Ca2+ fluxes were completely blocked by 10 μM CNQX
but not affected by 20 μM APV we assume that Ca2+ influxes
measured in our hiPSC-derived neurons were mediated by
glutamate receptors of the AMPA-, and not the NMDA subtype.
In summary, our data provide evidence that precondi-
tioning with RA during the neural induction phase of NPC
generation favours the relation of neuronal versus glial cells
and impacts on neurite lengths, especially axonal length
during terminal differentiation of hiPSCs. On the other
hand, RA treatment does not influence functional param-
eters of terminally differentiated neurons such as trans-
mitter induced excitability or neuronal plasticity estimated
by activity-dependent AIS movement. Therefore, early RA
treatment may be favourable for the neuronal differentiation
of hiPSCs resulting in a neuronal population with a predomi-
nantly glutamatergic phenotype.Abbreviations
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